TGF-β1 与左心室功能障碍有关
Bartosz Rakoczy1, Michal Rac2, Andrzej Krzystolik3
1Department of Clinical Radiology, University Hospital of Karol Marcinkowski, 26 Zyty St., 65-046 Zielona Góra, Poland.
Current issues in molecular biology
|October 28, 2025
概括
转化生长因子-β1 (TGF-β1) 在早期冠状动脉疾病 (CAD) 中显示出与心室功能障碍的微弱联系. 高TGF-β1与腹功能障碍和心律失常风险有关,而不是心脏病发作.
科学领域:
- 心血管研究研究心血管研究
- 动脉样硬化中的生物标志物
- 血管生物学 血管生物学
背景情况:
- 转化生长因子β1 (TGF-β1) 在动脉样硬化血管效应中的作用受到争议.
- 了解TGF-β1对早期冠状动脉疾病 (CAD) 和2型糖尿病 (T2DM) 的影响至关重要.
研究的目的:
- 在早期CAD患者中调查血TGF-β1度与心声学/血管参数之间的相关性.
- 评估TGF-β1与这一队列中的风险因素和疾病进展的关联.
主要方法:
- 在100名早期CAD患者的心声学和心电学.
- 多普勒超声波评估了动脉/臂动脉内心介质厚度,脚臂指数和动脉硬化斑块.
- 测量了血TGF-β1水平,并与临床和超声波发现相关联.
主要成果:
- 在TGF-β1和糖尿病,高血压,代谢综合征或心肌梗塞之间没有发现显著的相关性.
- 观察到与心室功能受损的弱相关性;与QRS宽度有很强的正相关性.
- 确定了TGF-β1与左心室透静功能障碍和心律失常风险之间的显著正相关性.
结论:
- 高血TGF-β1不与心脏病发作或早期CAD的常见风险因素有关,这表明稳定的斑块.
- 在早期CAD患者中,TGF-β1水平显著与左心室透静功能障碍和心律失常风险增加有关.
相关概念视频
Cardiomyopathy III: Hypertrophic Cardiomyopathy
393
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
393
Heart Failure II: Pathophysiology
704
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
704
TGF - β Signaling Pathway
10.5K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
10.5K
Mitral Regurgitation I: Introduction
402
Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
402
Pathophysiology of Heart Failure
2.8K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
2.8K
Mitral Stenosis I: Introduction
435
Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
435


